Why We Invested · Samsung Next
Investment thesis
Atropos Health provides a template for delivering data and insights effectively as Samsung expands its healthcare capabilities.
As Samsung expands its healthcare capabilities, Atropos Health can offer a template to deliver data and insights effectively.
Why the firm invested
Samsung Next invested in Atropos Health, a Stanford Medicine spinout, because it provides personalized, real-world evidence to inform clinical treatment decisions and research.
We invested in Atropos Health, a spinout from Stanford Medicine, because of their commitment to transforming healthcare by providing personalized, real-world evidence to inform clinical treatment decisions and research inquiries.
Product
Atropos Health leverages hundreds of millions of de-identified records to generate publication-grade real-world evidence reports called Prognostograms at unprecedented speeds.
Leveraging hundreds of millions of de-identified records, Atropos Health generates publication-grade real-world evidence reports, called Prognostograms, at unprecedented speeds.
Traction
Atropos Health collaborates with key partners including AWS, Datavant, Mayo Clinic Platform, and Stanford Health Care.
With key collaborators such as AWS, Datavant, Mayo Clinic Platform, and Stanford Health Care, research institutions and health tech giants alike are quickly realizing the potential of a solution like Atropos, and we are excited to follow suit.
Team
Atropos Health is led by co-founder and CEO Dr. Brigham Hyde alongside co-founders Dr. Saurabh Gombar and Dr. Nigam Shah.
Led by co-founder and CEO Dr. Brigham Hyde, the team boasts a diverse blend of clinical, research, investment, and operational expertise.
What founders can learn
- What actually moved the decision: Samsung Next wrote that Samsung Next invested in Atropos Health, a Stanford Medicine spinout, because it provides personalized, real-world evidence to inform clinical treatment decisions and research.
- The traction evidence that carried weight: Samsung Next wrote that Atropos Health collaborates with key partners including AWS, Datavant, Mayo Clinic Platform, and Stanford Health Care.
- How the team was judged: Samsung Next wrote that Atropos Health is led by co-founder and CEO Dr. Brigham Hyde alongside co-founders Dr. Saurabh Gombar and Dr. Nigam Shah.
Source and provenance
Why We Invested published by Samsung Next on samsungnext.com (first-party source). Read the original
